Financhill
Back

Xylem Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
41

XYL
Xylem

Last Price:
137.04
Seasonality Move:
7.35%
Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
40.76
Seasonality Move:
-0.9%
Sell
41
Xylem (XYL) is a Sell

Is Xylem a Buy, Sell or Hold?

  • The current Xylem [XYL] share price is $136.21. The Score for XYL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • XYL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XYL Stock Price Chart

What is Xylem's stock price today?

  • The Xylem share price today is $136.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XYL is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.50
    The current trend is relatively stagnant and RARE is experiencing slight buying pressure.

XYL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 42.58 Sell
Chaikin Money Flow: 623099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (137.2 - 142.3) Sell
Bollinger Bands (100): (124.72 - 139.2) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 494801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.79 - 41.97) Buy
Bollinger Bands (100): (40.81 - 48.79) Sell

XYL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 138.41 Sell
20-day SMA: 138.72 Sell
50-day SMA: 137.78 Sell
200-day SMA: 116.78 Buy
8-day EMA: 138.07 Sell
20-day EMA: 138.8 Sell
50-day EMA: 136.95 Sell
200-day EMA: 122.86 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.2 Buy
20-day SMA: 40.42 Buy
50-day SMA: 41.53 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.89 Buy
20-day EMA: 40.39 Buy
50-day EMA: 41.79 Sell
200-day EMA: 43.35 Sell

Xylem Earnings Growth & XYL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.08 per share, an increase this year of $0.49 per share, and an increase next year of $0.54 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Xylem Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):